Tahithromos’s Webster Financial WBS Stock Holding History

Tahithromos’s Portfolio WBS Stock Details WBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-189,802	Closed	-$6.81M	–	20
2016 Q1	$6.81M	Sell	189,802 -5,866	-3%	-$201K	7.73%	6
2015 Q4	$7.28M	Buy	195,668 +31,100	+19%	+$1.18M	6.92%	5
2015 Q3	$5.86M	Buy	+164,568	New	+$6.13M	5.46%	7

Other funds holding WBS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Tahithromos's WBS Position: Q2 2016 in Review

Tahithromos sold out of Webster Financial (WBS) in Q2 2016, closing a stake of 189,802 shares — an estimated $6.81M sold.

Tahithromos first reported a position in WBS in Q3 2015 and held it in 3 quarters. The position peaked at $7.28M in Q4 2015. 245 funds tracked by Wall St. Rank hold WBS as of Q2 2016.

Tahithromos reported no remaining Webster Financial position as of Q2 2016 after selling out during the quarter.
Tahithromos sold 189,802 Webster Financial shares in Q2 2016, an estimated $6.81M.
Tahithromos first reported a position in Webster Financial in Q3 2015 and held it in 3 quarters.
Tahithromos's Webster Financial position peaked at $7.28M in Q4 2015.
245 funds tracked by Wall St. Rank held Webster Financial as of Q2 2016.

Based on Tahithromos's 13F filing for Q2 2016, filed 28 Jul 2016.